EP 0957909 A1 19991124 - USE OF NITRIC OXID SYNTHASE INHIBITORS FOR THE TREATMENT OF DIABETES
Title (en)
USE OF NITRIC OXID SYNTHASE INHIBITORS FOR THE TREATMENT OF DIABETES
Title (de)
VERWENDUNG VON STICKSTOFFMONOXID-SYNTHASE INHIBITOREN ZUR BEHANDLUNG DER DIABETES
Title (fr)
INHIBITEURS DE LA LIGASE DU MONOXYDE D'AZOTE UTILISES DANS LE TRAITEMENT DES DIABETES
Publication
Application
Priority
EP 9700691 W 19970213
Abstract (en)
[origin: WO9835667A1] A method for the treatment and/or prophylaxis of Type II diabetes, which method comprises the administration, to a human or non-human mammal, of an effective non-toxic pharmaceutically acceptable amount of an NO synthase inhibitor, such as aminoguanidine, or a pharmaceutically acceptable derivative thereof.
IPC 1-7
IPC 8 full level
A61K 45/00 (2006.01); A61K 31/00 (2006.01); A61K 31/155 (2006.01); A61K 31/198 (2006.01); A61P 3/10 (2006.01)
CPC (source: EP)
A61K 31/00 (2013.01); A61K 31/155 (2013.01); A61K 31/198 (2013.01); A61P 3/10 (2017.12)
Citation (search report)
See references of WO 9835667A1
Designated contracting state (EPC)
BE CH DE ES FR GB IT LI NL
DOCDB simple family (publication)
WO 9835667 A1 19980820; AU 1725197 A 19980908; CA 2280871 A1 19980820; EP 0957909 A1 19991124; JP 2001512450 A 20010821
DOCDB simple family (application)
EP 9700691 W 19970213; AU 1725197 A 19970213; CA 2280871 A 19970213; EP 97904442 A 19970213; JP 53525798 A 19970213